S
Shanghai Fosun Pharmaceutical
Shanghai Fosun Pharmaceutical a leading healthcare company in China
At a glance
- Status
- Listed
- Listing
- IPO 2012
Open roles
Shanghai Fosun Pharmaceutical in the Baoshan District ecosystem
The Shanghai Fosun Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Patents
1,781 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Shanghai Fosun Pharmaceutical was the backer or acquirer, 2009–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
27 deals across Shanghai Fosun Pharmaceutical's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Shanghai Fosun Pharmaceutical deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Shanghai Fosun Pharmaceutical's portfolio, mapped.
See Shanghai Fosun Pharmaceutical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Accro Bioscience and Fosun enrol first patient in Phase 2/3 trial of AC-201 for vitiligo
Gland Pharma slips after ₹2,121 Cr block deal; Fosun Pharma likely seller
